{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:54:23Z","timestamp":1790988863167,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1421,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001594","name":"Irish Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jacc.2009.08.021","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T08:54:29Z","timestamp":1256115269000},"page":"1674-1682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Natural History of Markers of Collagen Turnover in Patients With Early Diastolic Dysfunction and Impact of Eplerenone"],"prefix":"10.1016","volume":"54","author":[{"given":"George J.","family":"Mak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Ledwidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot M.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Dawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh F.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Patle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Baugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.08.021_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.021_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.021_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.08.021_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jacc.2006.08.062","article-title":"Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence","volume":"49","author":"Persson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.021_bib5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.106.638569","article-title":"Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction","volume":"115","author":"Martos","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.CIR.93.5.1026","article-title":"Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis","volume":"93","author":"Diez","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardfail.2008.02.014","article-title":"Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure","volume":"14","author":"Radauceanu","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2009.08.021_bib8","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.021_bib9","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.08.021_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.08.021_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone","volume":"26","author":"Brilla","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2009.08.021_bib12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/hc1202.105290","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib13","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.08.021_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejheart.2006.10.005","article-title":"Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker","volume":"9","author":"Berry","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2009.08.021_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2009.08.021_bib16","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","article-title":"Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure","volume":"110","author":"Mottram","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2009.08.021_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/hc0502.103010","article-title":"Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings","volume":"105","author":"Lubien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib20","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib22","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.CIR.91.5.1450","article-title":"Increased serum concentrations of procollagen peptides in essential hypertension","volume":"91","author":"Diez","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/ajh\/7.1.52","article-title":"Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension","volume":"7","author":"Laviades","year":"1994","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2009.08.021_bib24","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/hy1101.098549","article-title":"Biochemical assessment of myocardial fibrosis in hypertensive heart disease","volume":"38","author":"Lopez","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.08.021_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejheart.2005.06.008","article-title":"Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes","volume":"8","author":"Alla","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2009.08.021_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/hrt.2003.018424","article-title":"Time course of plasma markers of collagen turnover in patients with acute myocardial infarction","volume":"90","author":"McGavigan","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2009.08.021_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.HYP.0000208840.30778.00","article-title":"Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload","volume":"47","author":"Matsusaka","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.08.021_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1253\/circj.71.716","article-title":"Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide","volume":"71","author":"Nakahara","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2009.08.021_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/hrt.2003.029702","article-title":"Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension","volume":"91","author":"Poulsen","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2009.08.021_bib30","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0735-1097(94)00557-7","article-title":"Dilated cardiomyopathy is associated with an increase in the type I\/type III collagen ratio: a quantitative assessment","volume":"25","author":"Marijianowski","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.021_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1071-9164(99)90034-9","article-title":"Left and right ventricular collagen type I\/III ratios and remodeling post-myocardial infarction","volume":"5","author":"Wei","year":"1999","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2009.08.021_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurjhf\/hfn036","article-title":"Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover","volume":"11","author":"Martos","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2009.08.021_bib33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"Diez","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.021_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00226785","article-title":"Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts","volume":"154","author":"Zhou","year":"1996","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacc.2009.08.021_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/hy0202.103481","article-title":"Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors","volume":"39","author":"Ammarguellat","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.08.021_bib36","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacc.2009.08.021_bib37","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2009.08.021_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.HYP.0000118586.38323.5b","article-title":"From inflammation to fibrosis: a stiff stretch of highway","volume":"43","author":"Weber","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.08.021_bib39","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1097\/HJH.0b013e32830e2545","article-title":"Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension","volume":"26","author":"Navarro-Gonzalez","year":"2008","journal-title":"J Hypertens"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709029271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709029271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:35:30Z","timestamp":1760013330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709029271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":39,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0735109709029271"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.08.021","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural History of Markers of Collagen Turnover in Patients With Early Diastolic Dysfunction and Impact of Eplerenone","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}